Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation



      In Hong Kong, about 30% of non-small cell lung cancer patients have never smoked tobacco. Among women, 83% are never-smokers and their histological type is invariably adenocarcinoma with 70% incidence of epidermal growth factor receptor (EGFR) mutation. The present study focuses on the microRNA (miRNA) expression profiles of this important subset of lung cancer.


      Paired samples collected from the lung cancer tissue and adjacent normal lung parenchyma of 10 non-smoking patients with lung adenocarcinoma were profiled by miRNA microarray. Results were validated by quantitative reverse transcription polymerase chain reaction. Transfected cell viability assays were applied to determine the effects of candidate miRNAs on lung cancer cells.


      Comparing paired lung cancer tissue with adjacent normal lung parenchyma, hsa-miR-126, hsa-miR-145, hsa-miR-21, hsa-miR-182, hsa-miR-183 and hsa-miR-210 were found to be the most differentially expressed miRNAs. Most interestingly, an obvious inhibition of cell growth was observed in the EGFR mutant lung adenocarcinoma after transfection of hsa-pre-miR-145.


      Our study is the first report to connect miR-182 to lung cancer. Our results also show that restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in EGFR mutant lung adenocarcinoma. Further study on these specific differentially expressed miRNAs may provide important information on peculiar tumourigenetic pathways and may identify useful biomarkers.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to European Journal of Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Thun M.J.
        • Hannan L.M.
        • Adams-Campbell L.L.
        • et al.
        Lung cancer occurrence in never-smokers: an analysis of 13 cohorts, 22 cancer registry studies.
        PLoS Med. 2008; 5: e185
        • Toh C.K.
        • Lim W.T.
        Lung cancer in never-smokers.
        J Clin Pathol. 2007; 60: 337-340
        • Wakelee H.A.
        • Chang E.T.
        • Gomez S.L.
        • et al.
        Lung cancer incidence in never smokers.
        J Clin Oncol. 2007; 25: 472-478
        • Au J.S.
        • Cho W.C.
        • Yip T.T.
        • et al.
        Deep proteome profiling of sera from never-smoked lung cancer patients.
        Biomed Pharmacother. 2007; 61: 570-577
        • Sun S.
        • Schiller J.H.
        • Gazdar A.F.
        Lung cancer in never smokers – a different disease.
        Nat Rev Cancer. 2007; 7: 778-790
        • Yen C.C.
        • Liang S.C.
        • Jong Y.J.
        • et al.
        Chromosomal aberrations of malignant pleural effusions of lung adenocarcinoma: different cytogenetic changes are correlated with genders and smoking habits.
        Lung Cancer. 2007; 57: 292-301
        • Mountzios G.
        • Fouret P.
        • Soria J.C.
        Mechanisms of disease: signal transduction in lung carcinogenesis – a comparison of smokers and never-smokers.
        Nat Clin Pract Oncol. 2008; 5: 610-618
        • Cho W.C.
        Potentially useful biomarkers for the diagnosis, treatment and prognosis of lung cancer.
        Biomed Pharmacother. 2007; 61: 515-519
        • Lagos-Quintana M.
        • Rauhut R.
        • Lendeckel W.
        • Tuschl T.
        Identification of novel genes coding for small expressed RNAs.
        Science. 2001; 294: 853-858
        • Calin G.A.
        • Croce C.M.
        MicroRNA signatures in human cancers.
        Nat Rev Cancer. 2006; 6: 857-866
        • Cho W.C.
        OncomiRs: the discovery and progress of microRNAs in cancers.
        Mol Cancer. 2007; 6: 60
        • Au J.S.
        • Cho W.C.
        • Yip T.T.
        • Law S.C.
        Proteomic approach to biomarker discovery in cancer tissue from lung adenocarcinoma among nonsmoking Chinese women in Hong Kong.
        Cancer Invest. 2008; 26: 128-135
        • Miura K.
        • Bowman E.D.
        • Simon R.
        • et al.
        Laser capture microdissection and microarray expression analysis of lung adenocarcinoma reveals tobacco smoking- and prognosis-related molecular profiles.
        Cancer Res. 2002; 62: 3244-3250
        • Powell C.A.
        • Spira A.
        • Derti A.
        • et al.
        Gene expression in lung adenocarcinomas of smokers and nonsmokers.
        Am J Respir Cell Mol Biol. 2003; 29: 157-162
        • Heguy A.
        • O’Connor T.P.
        • Luettich K.
        • et al.
        Gene expression profiling of human alveolar macrophages of phenotypically normal smokers and nonsmokers reveals a previously unrecognized subset of genes modulated by cigarette smoking.
        J Mol Med. 2006; 84: 318-328
        • Messersmith W.A.
        • Ahnen D.J.
        Targeting EGFR in colorectal cancer.
        New Engl J Med. 2008; 359: 1834-1836
        • Kelly M.P.
        • Lee S.T.
        • Lee F.T.
        • et al.
        Therapeutic efficacy of 177Lu-CHX-A”-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by EGFR inhibition or docetaxel chemotherapy.
        Prostate. 2009; 69: 92-104
        • Toyama T.
        • Yamashita H.
        • Kondo N.
        • et al.
        Frequently increased epidermal growth factor receptor (EGFR) copy numbers, decreased BRCA1 mRNA expression in Japanese triple-negative breast cancers.
        BMC Cancer. 2008; 8: 309
        • Ding L.
        • Getz G.
        • Wheeler D.A.
        • et al.
        Somatic mutations affect key pathways in lung adenocarcinoma.
        Nature. 2008; 455: 1069-1075
        • Morinaga R.
        • Okamoto I.
        • Fujita Y.
        • et al.
        Association of epidermal growth factor receptor (EGFR) gene mutations with EGFR amplification in advanced non-small cell lung cancer.
        Cancer Sci. 2008; 99: 2455-2460
        • Sonobe M.
        • Manabe T.
        • Wada H.
        • Tanaka F.
        Mutations in the epidermal growth factor receptor gene are linked to smoking-independent, lung adenocarcinoma.
        Br J Cancer. 2005; 93: 355-363
        • Iorio M.V.
        • Ferracin M.
        • Liu C.G.
        • et al.
        MicroRNA gene expression deregulation in human breast cancer.
        Cancer Res. 2005; 65: 7065-7070
        • Meng F.
        • Henson R.
        • Lang M.
        • et al.
        Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines.
        Gastroenterology. 2006; 130: 2113-2129
        • Tran N.
        • McLean T.
        • Zhang X.
        • et al.
        MicroRNA expression profiles in head and neck cancer cell lines.
        Biochem Biophys Res Commun. 2007; 358: 12-17
        • Fulci V.
        • Chiaretti S.
        • Goldoni M.
        • et al.
        Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia.
        Blood. 2007; 109: 4944-4951
        • Markou A.
        • Tsaroucha E.G.
        • Kaklamanis L.
        • et al.
        Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR.
        Clin Chem. 2008; 54: 1696-1704
        • Musiyenko A.
        • Bitko V.
        • Barik S.
        Ectopic expression of miR-126∗, an intronic product of the vascular endothelial EGF-like 7 gene, regulates prostein translation and invasiveness of prostate cancer LNCaP cells.
        J Mol Med. 2008; 86: 313-322
        • Bandres E.
        • Cubedo E.
        • Agirre X.
        • et al.
        Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer, non-tumoral tissues.
        Mol Cancer. 2006; 5: 29
        • Wang X.
        • Tang S.
        • Le S.Y.
        • et al.
        Aberrant expression of oncogenic, tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth.
        PLoS ONE. 2008; 3: e2557
        • Camps C.
        • Buffa F.M.
        • Colella S.
        • et al.
        Hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer.
        Clin Cancer Res. 2008; 14: 1340-1348
        • Giannakakis A.
        • Sandaltzopoulos R.
        • Greshock J.
        • et al.
        MiR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer.
        Cancer Biol Ther. 2008; 7: 255-264
        • Lawrie C.H.
        • Gal S.
        • Dunlop H.M.
        • et al.
        Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma.
        Br J Haematol. 2008; 141: 672-675
        • Michael M.Z.
        • O’Connor S.M.
        • van Holst Pellekaan N.G.
        • Young G.P.
        • James R.J.
        Reduced accumulation of specific microRNAs in colorectal neoplasia.
        Mol Cancer Res. 2003; 1: 882-891
        • Diederichs S.
        • Haber D.A.
        Sequence variations of microRNAs in human cancer: alterations in predicted secondary structure do not affect processing.
        Cancer Res. 2006; 66: 6097-6104
        • Izzotti A.
        • Calin G.A.
        • Arrigo P.
        • et al.
        Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke.
        FASEB J. 2009; 23: 806-812